Hisun (Vancomycin Hcl)

“Gold Standard Treatment for MRSA”

Hisun for injection is an antibiotic brand of Vancomycin Hcl, which represents the therapeutic class of glycopeptides. Hisun (Vancomycin Hcl) is as consider drug of choice for the treatment of Methicillin Resistant Staphylococcus aureus (MRSA), a gram positive organism in involve in hard to treat infections. Hisun (Vancomycin Hcl) susceptibility is also proven in number of gram positive pathogens. In Pakistan Hisun (Vancomycin Hcl) is well accepted by clinicians and is now recommended as an important therapeutic choice by virtue of its clinical significance and economy.


Skin and soft tissues, Osteomyelitis, diabetic foot infections, Bacteremia, Septicemia, Neonatal Sepsis, Cardiac surgery, Prosthetic surgeries, and in Hemodialysis Infections. Beside MRSA, clinical efficacy of Hisun is well documented for the treatment of Endocarditis.

Dosage Guidelines:

The recommended therapeutic dose of Hisun is 2 gm given either as 500 mg every 6 hourly or 1 gram every 12 hourly. Hisun should be reconstituted before administration.


Hisun is a niche market product available in 500 mg and 1 gm vials for IV usage.


Hisun should be stored at or below 20˚C in a cool dark and dry place.

Biocare Pharmaceutica Sales Trend (2005-2015)